“Bimekizumab Efficacy and Safety in Patients With Psoriatic Arthritis Who Had Skin and Nail Psoriasis at Baseline: Up to 2-Year Results From Two Phase 3 Studies”. SKIN The Journal of Cutaneous Medicine, vol. 8, no. 6, Nov. 2024, p. s435, https://doi.org/10.25251/skin.8.supp.435.